Streetbeat News

Analyst Ratings

ARCT

Cantor Fitzgerald analyst Pete Stavropoulos has reiterated an Overweight rating on Arcturus Therapeutics (NASDAQ:ARCT) and maintained a $54 price target.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:47 pm

NOTE

Northland Capital Markets has reiterated its 'Outperform' rating on FiscalNote Holdings (NYSE:NOTE) and maintained its $9 price target.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:45 pm

SYF

JMP Securities analyst David Scharf has reiterated a 'Market Outperform' rating on Synchrony Financial (SYF) and maintained a price target of $42.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:36 pm

STWD

JMP Securities analyst Steven Delaney has maintained a 'Market Outperform' rating on Starwood Prop Trust (NYSE:STWD), but lowered the price target from $26 to $24.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:35 pm

OMF

JMP Securities analyst David Scharf has reiterated a Market Outperform rating on OneMain Holdings (NYSE:OMF) and maintained a $55 price target.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:34 pm

LPRO

JMP Securities analyst David Scharf maintains a Market Outperform rating on Open Lending (NASDAQ:LPRO) and raises the price target from $10 to $12.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:34 pm

ENVA

JMP Securities analyst David Scharf maintains a Market Outperform rating on Enova International (NYSE:ENVA) and raises the price target from $61 to $70.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:33 pm

ECPG

JMP Securities analyst David Scharf has reiterated a 'Market Outperform' rating on Encore Capital Gr (NASDAQ:ECPG) and maintained a price target of $61.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:33 pm

ACAD

JMP Securities analyst Jason Butler maintains a Market Outperform rating on ACADIA Pharmaceuticals and raises the price target from $31 to $39.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:32 pm

RRC

Benchmark analyst Subash Chandra maintains a Buy rating on Range Resources (NYSE:RRC) and raises the price target from $32 to $39.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:30 pm